期刊文献+

mTOR信号通路调节HIF-1α及VEGF 被引量:14

mTOR signaling pathway regulates HIF-1α and VEGF
原文传递
导出
摘要 哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)是一种非典型丝氨酸/苏氨酸蛋白激酶,可整合营养、能量及生长因子等多种细胞外信号,参与基因转录、蛋白质翻译、核糖体合成等生物过程,在细胞生长和细胞程序性死亡中发挥极为重要的作用。研究表明,mTOR信号通路可能通过调节下游靶蛋白来调控细胞生物过程,如缺氧诱导因子(hypoxia-inducible factor,HIF-1α,血管内皮生长因子(vascular endothelial growth factor,VEGF)等。mTOR通过调节这些细胞因子,可能影响蛋白质合成、血管生成和细胞凋亡自噬等,从而影响疾病发展和结局,这为mTOR成为疾病治疗靶点提供证据。 The mammalian target of rapamycin (mTOR) is an evolutionarily conserved atypical Ser/Thr protein kinase, functioning as a sensor of extracellular signals from nutrients, oxygen, energy and growth factors. Through modulating its downstream targets in the cellular nucleus, roTOR regulates transcription, cell growth, protein translation, proliferation, survival and programmed cell death. It is proved that mTOR can regulate the cellular biological processes through some cytokines, such as hypoxia-inducible factor (HIF-1α), vascular endothelial growth factor (VEGF), etc. These processes include protein synthesis, angiogenesis, apoptosis or autophagy, which participate in the pathological or survival mechanisms of diseases. Therefore, roTOR could become a candidate target for treatment of diseases.
出处 《生命的化学》 CAS CSCD 北大核心 2011年第6期838-843,共6页 Chemistry of Life
基金 国家自然科学基金项目(30825039 30973236 81172174) 教育部长江学者和创新团队基金(IRT0935) 四川省科技厅基金项目(2010SZ0280)资助
  • 相关文献

参考文献4

二级参考文献111

  • 1张俊峰,陈规划,陆敏强,蔡常洁,杨扬,李华,易慧敏.雷帕霉素诱导人肝癌细胞BEL-7402凋亡中Bcl-2作用研究[J].中华肿瘤防治杂志,2006,13(19):1445-1448. 被引量:8
  • 2马湘一,王世宣,刘琰,刘荣华,卢运萍,马丁.雷帕霉素联合紫杉醇诱导卵巢癌细胞A2780和SKOV3凋亡及其分子机制[J].癌症,2007,26(4):367-370. 被引量:12
  • 3Yang XY, Jiang SOL Zhang L, Liu QN, Gong PL. Inhibitory effect of dauricine on inflammatory process following focal cerebral ischemia/reperfusion in rats. AmJ Chin Med 2007; 35: 477-86.
  • 4Su YM, Zhang C, Xiao JY, Gang HL, Wang ZG, Hua D. Effects of PAMD on the proliferation of human tumor cells of PC-3 and BT5637. Harbin Yi Ke Da Xue Xue Ba 2007; 41: 129-31. Chinese.
  • 5Al-Harris ES, Al-Janabi AA, Al-Toriahi KM, Yasseen AA. Over expression of vascular endothelial growth factor in correlation to Ki-67, grade, and stage of breast cancer. Saudi Med J 2008; 29: 1099-104.
  • 6Applanat ME Buteau-Lozano H, Herve MA, Corpet A. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression. Adv Exp Med Bio12008; 617: 437-44.
  • 7Slomiany MG, Rosenzweig SA. Hypoxia-inducible factor- dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion. J Pharmacol Exp Ther 2006; 318: 666-75.
  • 8Catrina SB, Botusan IR, Rantanen A, Catrina AI, Pyakurel P, Savu O, et al. Hypoxia-inducible factor-lalpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I. Clin Cancer Res 2006; 12: 4506-14.
  • 9Beppu K, Nakamura K, Linehan WM, Rapisarda A, Thiele CJ. Topotecan blocks hypoxia-inducible factor-lalpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells. Cancer Res 2005; 65: 4775-81.
  • 10Cao Z, Fang J, Xia C, Shi X, Jiang BH. trans-3,4,5'-Trihydroxy- stibene inhibits hypoxia-inducible factor lalpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 2004; 10: 5253-63.

共引文献89

同被引文献183

引证文献14

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部